ArticleJournal of clinical medicine2026

Enzalutamide Versus Abiraterone After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Real-World Outcomes and Exploratory Prognostic Stratification.

Mert Tohumcuoğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.